CRBP
Price
$9.00
Change
-$0.11 (-1.21%)
Updated
Aug 7 closing price
Capitalization
110.13M
ROQAF
Price
$0.02
Change
-$0.03 (-60.00%)
Updated
Jul 14 closing price
Capitalization
3.45M
Interact to see
Advertisement

CRBP vs ROQAF

Header iconCRBP vs ROQAF Comparison
Open Charts CRBP vs ROQAFBanner chart's image
Corbus Pharmaceuticals Holdings
Price$9.00
Change-$0.11 (-1.21%)
Volume$88.8K
Capitalization110.13M
Roquefort Therapeutics
Price$0.02
Change-$0.03 (-60.00%)
Volume$1K
Capitalization3.45M
CRBP vs ROQAF Comparison Chart in %
Loading...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBP vs. ROQAF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a Hold and ROQAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CRBP: $9.00 vs. ROQAF: $0.02)
Brand notoriety: CRBP and ROQAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 56% vs. ROQAF: 131%
Market capitalization -- CRBP: $110.13M vs. ROQAF: $3.45M
CRBP [@Biotechnology] is valued at $110.13M. ROQAF’s [@Biotechnology] market capitalization is $3.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileROQAF’s FA Score has 1 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • ROQAF’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBP is a better buy in the long-term than ROQAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 5 TA indicator(s) are bullish while ROQAF’s TA Score has 0 bullish TA indicator(s).

  • CRBP’s TA Score: 5 bullish, 5 bearish.
  • ROQAF’s TA Score: 0 bullish, 2 bearish.
According to our system of comparison, CRBP is a better buy in the short-term than ROQAF.

Price Growth

CRBP (@Biotechnology) experienced а -2.91% price change this week, while ROQAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($110M) has a higher market cap than ROQAF($3.46M). CRBP YTD gains are higher at: -23.729 vs. ROQAF (-57.300).
CRBPROQAFCRBP / ROQAF
Capitalization110M3.46M3,184%
EBITDA-48.74MN/A-
Gain YTD-23.729-57.30041%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash133MN/A-
Total Debt2.86MN/A-
FUNDAMENTALS RATINGS
CRBP: Fundamental Ratings
CRBP
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBPROQAF
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
20%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTTR79.651.07
+1.36%
Otter Tail Corp
CGBD13.660.06
+0.44%
Carlyle Secured Lending
NWG14.140.04
+0.28%
NatWest Group plc
SGLY0.96N/A
N/A
Singularity Future Technology Ltd
HAO1.18-0.03
-2.50%
Haoxi Health Technology Limited

CRBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBP has been loosely correlated with SKYE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBP jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBP
1D Price
Change %
CRBP100%
-1.21%
SKYE - CRBP
47%
Loosely correlated
-8.74%
FBIO - CRBP
40%
Loosely correlated
-1.60%
STOK - CRBP
36%
Loosely correlated
+0.61%
APLS - CRBP
35%
Loosely correlated
+2.53%
XBIT - CRBP
31%
Poorly correlated
+0.69%
More

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
GNTA - ROQAF
36%
Loosely correlated
N/A
CRBP - ROQAF
22%
Poorly correlated
-1.21%
SVRA - ROQAF
21%
Poorly correlated
-4.01%
SKYE - ROQAF
21%
Poorly correlated
-8.74%
SNTI - ROQAF
6%
Poorly correlated
-8.88%
More